Home LiteratureArticle Details
PMID: 18780892 Published · epublish English Journal Article

Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development.

Science signaling ·Vol. 1 ·No. 36 ·2008-09-09 ·Pages ra3

Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C, Azzolino O, Gonella C, Rubinetto C, Wu H, Dastrù W, Martin EL, Silengo L, Altruda F, Turco E, Lanzetti L, Musiani P, Rückle T, Rommel C, Backer JM, Forni G, Wymann MP, Hirsch E

Abstract

The phosphoinositide 3-kinase (PI3K) pathway crucially controls metabolism and cell growth. Although different PI3K catalytic subunits are known to play distinct roles, the specific in vivo function of p110beta (the product of the PIK3CB gene) is not clear. Here, we show that mouse mutants expressing a catalytically inactive PIK3CB(K805R) mutant survived to adulthood but showed growth retardation and developed mild insulin resistance with age. Pharmacological and genetic analyses of p110beta function revealed that p110beta catalytic activity is required for PI3K signaling downstream of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors as well as to sustain long-term insulin signaling. In addition, PIK3CB(K805R) mice were protected in a model of ERBB2-driven tumor development. These findings indicate an unexpected role for p110beta catalytic activity in diabetes and cancer, opening potential avenues for therapeutic intervention.

MeSH Terms
Aging/physiology Animals Cell Transformation, Neoplastic/metabolism,pathology Cells, Cultured Class I Phosphatidylinositol 3-Kinases Diabetes Mellitus, Experimental/enzymology Endocytosis Insulin Resistance/physiology Mammary Neoplasms, Experimental/enzymology,pathology Mice Mice, Mutant Strains Phosphatidylinositol 3-Kinases/genetics,physiology Receptor, ErbB-2/physiology Signal Transduction
Chemicals
Phosphatidylinositol 3-Kinases 1-phosphatidylinositol 3-kinase p110 subunit, mouse Class I Phosphatidylinositol 3-Kinases Erbb2 protein, mouse Receptor, ErbB-2
Authors & Affiliations
23 authors, click to expand affiliations / ORCID
Ciraolo Elisa
Department of Genetics, Biology and Biochemistry, Molecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.
Iezzi Manuela
Marone Romina
Marengo Stefano
Curcio Claudia
Costa Carlotta
Azzolino Ornella
Gonella Cristiano
Rubinetto Cristina
Wu Haiyan
Dastrù Walter
Martin Erica L
Silengo Lorenzo
Altruda Fiorella
Turco Emilia
Lanzetti Letizia
Musiani Piero
Rückle Thomas
Rommel Christian
Backer Jonathan M
Forni Guido
Wymann Matthias P
Hirsch Emilio
References (37)
37 references, click to expand
  1. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing.
    Thromb Haemost. 2006 Jan;95(1):29-35 PMID: 16543958
  2. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
    Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10578-82 PMID: 1359541
  3. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.
    J Exp Med. 1998 Aug 3;188(3):589-96 PMID: 9687535
  4. Rab5 is a signalling GTPase involved in actin remodelling by receptor tyrosine kinases.
    Nature. 2004 May 20;429(6989):309-14 PMID: 15152255
  5. eps15 and eps15R are essential components of the endocytic pathway.
    Cancer Res. 1997 Dec 15;57(24):5498-504 PMID: 9407958
  6. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
    Biochem J. 2007 Jun 15;404(3):449-58 PMID: 17362206
  7. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
    Cancer Res. 2005 Apr 1;65(7):2554-9 PMID: 15805248
  8. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.
    Oncogene. 2000 Oct 19;19(44):5083-90 PMID: 11042696
  9. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.
    Nature. 2006 May 18;441(7091):366-70 PMID: 16625210
  10. PI 3-kinase p110beta: a new target for antithrombotic therapy.
    Nat Med. 2005 May;11(5):507-14 PMID: 15834429
  11. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.
    Nat Rev Genet. 2006 Aug;7(8):606-19 PMID: 16847462
  12. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
    Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8292-7 PMID: 18544649
  13. Phosphatidylinositol-3-OH kinases are Rab5 effectors.
    Nat Cell Biol. 1999 Aug;1(4):249-52 PMID: 10559924
  14. ERBB receptors and cancer: the complexity of targeted inhibitors.
    Nat Rev Cancer. 2005 May;5(5):341-54 PMID: 15864276
  15. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.
    Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1289-94 PMID: 16432180
  16. Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure.
    Biochem J. 2005 Feb 1;385(Pt 3):639-48 PMID: 15554902
  17. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer.
    Nat Clin Pract Oncol. 2006 May;3(5):269-80 PMID: 16683005
  18. Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight: potential link to increased risk of diabetes?
    Diabetologia. 2006 Dec;49(12):2993-9 PMID: 17063325
  19. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
    J Clin Invest. 2004 Mar;113(5):709-17 PMID: 14991069
  20. Phosphoinositide 3-kinase in disease: timing, location, and scaffolding.
    Curr Opin Cell Biol. 2005 Apr;17(2):141-9 PMID: 15780590
  21. Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.
    Mol Cell Biol. 2004 Feb;24(3):966-75 PMID: 14729945
  22. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
    Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7 PMID: 15647370
  23. From mice to men: insights into the insulin resistance syndromes.
    Annu Rev Physiol. 2006;68:123-58 PMID: 16460269
  24. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.
    Mol Cell Biol. 2005 Mar;25(5):1596-607 PMID: 15713620
  25. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.
    Cell. 2006 May 19;125(4):733-47 PMID: 16647110
  26. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling.
    J Endocrinol. 2007 Aug;194(2):243-56 PMID: 17641274
  27. An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway.
    J Cell Biol. 2005 Aug 15;170(4):607-18 PMID: 16103228
  28. Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.
    Mamm Genome. 2002 Mar;13(3):169-72 PMID: 11919689
  29. Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma.
    J Biol Chem. 1999 Oct 8;274(41):29311-7 PMID: 10506190
  30. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
    Nature. 2008 Aug 7;454(7205):776-9 PMID: 18594509
  31. Oncogenic PI3K deregulates transcription and translation.
    Nat Rev Cancer. 2005 Dec;5(12):921-9 PMID: 16341083
  32. Cancer-specific mutations in PIK3CA are oncogenic in vivo.
    Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1475-9 PMID: 16432179
  33. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
    Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18443-8 PMID: 16339315
  34. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.
    Cell. 2004 Aug 6;118(3):375-87 PMID: 15294162
  35. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta.
    Cell Metab. 2006 May;3(5):343-53 PMID: 16679292
  36. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
    Science. 2002 Aug 9;297(5583):1031-4 PMID: 12130661
  37. A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt.
    J Biol Chem. 2000 Apr 21;275(16):12069-73 PMID: 10766839
Article Info
Journal
Science signaling
Abbr.
Sci Signal
ISSN
1937-9145
DOI
10.1126/scisignal.1161577
Published
2008-09-09
Epub
2008-00-09
Pages
ra3
Language
English
Region
United States
NLM ID
101465400
PMCID
PMC2694958
Subset
IM
Grants
Telethon · GGP05113 · Italy
NIGMS NIH HHS · R01 GM055692 · United States
NIGMS NIH HHS · R01 GM055692-11 · United States
External Links
PubMed source DOI: 10.1126/scisignal.1161577 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2